# Open Label Trial of Triheptanoin (UX007) in Treatment of Rett Syndrome.

> **NCT03059160** · PHASE2 · UNKNOWN · sponsor: **Sheba Medical Center** · enrollment: 10 (estimated)

## Conditions studied

- Rett Syndrome

## Interventions

- **DRUG:** Tridecanoic Acid

## Key facts

- **NCT ID:** NCT03059160
- **Lead sponsor:** Sheba Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-04-01
- **Primary completion:** 2018-04-01
- **Final completion:** 2018-08-01
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2017-02-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03059160

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03059160, "Open Label Trial of Triheptanoin (UX007) in Treatment of Rett Syndrome.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03059160. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*